Disease ID | Disease name | Source of annotation with FOXO1 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
268220 | RHABDOMYOSARCOMA 2 | OMIM | link to OMIM | 3 | FOXO1, PAX7, PAX3 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Prostate cancer | hsa05215 | 6.11 |
Pathways in cancer | hsa05200 | 3.98 |
Transcriptional misregulation in cancer | hsa05202 | 5.21 |
Insulin signaling pathway | hsa04910 | 5.55 |
FoxO signaling pathway | hsa04068 | 5.63 |
Thyroid hormone signaling pathway | hsa04919 | 5.82 |
AMPK signaling pathway | hsa04152 | 5.8 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Regulation of gene expression in beta cells | R-HSA-210745 | 8.66 |
PI3K/AKT activation | R-HSA-198203 | 6.32 |
Immune System | R-HSA-168256 | 2.37 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
Downstream signal transduction | R-HSA-186763 | 4.65 |
GAB1 signalosome | R-HSA-180292 | 6.31 |
Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
Developmental Biology | R-HSA-1266738 | 3.48 |
Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
Signalling by NGF | R-HSA-166520 | 4.23 |
PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.4 |
Disease | R-HSA-1643685 | 3.33 |
AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 10.98 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
Signaling by FGFR | R-HSA-190236 | 4.67 |
PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
Diseases of signal transduction | R-HSA-5663202 | 4.89 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.54 |
Innate Immune System | R-HSA-168249 | 3.17 |
Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.81 |
Signaling by PDGF | R-HSA-186797 | 4.53 |
DAP12 signaling | R-HSA-2424491 | 4.64 |
PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
Regulation of beta-cell development | R-HSA-186712 | 7.98 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
DAP12 interactions | R-HSA-2172127 | 4.56 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
Signal Transduction | R-HSA-162582 | 1.78 |
GO term | GO ID | GO IC |
---|---|---|
ubiquitin-like protein ligase binding | GO:0044389 | 4.15 |
enzyme binding | GO:0019899 | 2.27 |
macromolecular complex binding | GO:0044877 | 2.61 |
binding | GO:0005488 | 0.18 |
nucleic acid binding | GO:0003676 | 1.44 |
DNA binding | GO:0003677 | 1.92 |
transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding | GO:0001078 | 5.08 |
heterocyclic compound binding | GO:1901363 | 1.06 |
sequence-specific DNA binding | GO:0043565 | 2.79 |
transcription factor activity, transcription factor binding | GO:0000989 | 3.36 |
transcription factor activity, protein binding | GO:0000988 | 3.35 |
transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding | GO:0000982 | 3.94 |
RNA polymerase II transcription factor activity, sequence-specific DNA binding | GO:0000981 | 3.29 |
transcription factor binding | GO:0008134 | 3.46 |
beta-catenin binding | GO:0008013 | 5.3 |
protein phosphatase binding | GO:0019903 | 4.93 |
phosphatase binding | GO:0019902 | 4.63 |
protein phosphatase 2A binding | GO:0051721 | 6.41 |
transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding | GO:0001227 | 4.61 |
ubiquitin protein ligase binding | GO:0031625 | 4.17 |
transcription cofactor binding | GO:0001221 | 6.52 |
transcription coactivator binding | GO:0001223 | 7.34 |
transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
organic cyclic compound binding | GO:0097159 | 1.05 |
protein binding | GO:0005515 | 0.46 |
chromatin binding | GO:0003682 | 3.64 |
nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |